Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A notable pilot study involved 12 children with severe treatment-resistant inflammatory bowel disease (IBD), including Crohns disease and ulcerative colitis
Fact-checked by Jack White, Editorial Standards Lead
Maintaining normal conditions at the injection site keeps absorption predictable
Classified as a gut repair peptide, BPC-157 has been shown in preclinical studies to support tissue regeneration, reduce inflammation, and enhance blood flowespecially in the digestive tract
Avoid products making exaggerated health claims or those containing unnecessary additives
The primary molecular mechanism of TB-500 involves regulation of actin dynamics through its high-affinity binding to monomeric G-actin
